22.03
price down icon1.39%   -0.31
after-market Handel nachbörslich: 22.54 0.51 +2.32%
loading

Finanzdaten der Arrowhead Pharmaceuticals Inc-Aktie (ARWR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-30 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
94.88%
27.77
542.71 2.50 - -
Operating Expenses
19.70%
193.32
161.51 163.91 162.20 176.14
Benefits Costs and Expenses
19.51%
206.86
173.09 177.62 172.80 173.98
Costs And Expenses
19.51%
206.86
173.09 177.62 172.80 173.98
Depreciation and Amortization
6.223
- - 5.025 4.782
Operating Income/Loss
143.43%
-165.55
381.20 -161.41 -162.20 -176.14
Nonoperating Income/Loss
16.86%
-13.54
-11.59 -13.70 -10.60 2.164
Income/Loss From Continuing Operations Before Tax
148.45%
-179.09
369.62 -175.22 -172.80 -173.98
Income Tax Expense/Benefit
124.93%
-0.437
1.753 0.103 0.546 -
Income/Loss From Continuing Operations After Tax
148.56%
-178.65
367.86 -175.22 -173.34 -173.98
Net Income/Loss
148.56%
-178.65
367.86 -175.22 -173.34 -173.98
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
32.11%
-3.411
-2.582 - -2.808 -3.184
Basic Average Shares
4.26%
139.04
133.36 -4.304 1.524 124.20
Diluted Average Shares
3.39%
139.04
134.48 -4.219 1.524 124.20
Basic Earnings Per Share
145.32%
-1.26
2.78 -1.25 -1.37 -1.38
Diluted Earnings Per Share
145.82%
-1.26
2.75 -1.23 -1.37 -1.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Kapitalisierung:     |  Volumen (24h):